Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 11
- Adult-Use
Switzerland Launches Eighth Cannabis Pilot, Testing Home Delivery for the First Time
Switzerland has granted approval for a new five-year, 5000-participant adult-use cannabis pilot trial, marking the eighth since the groundbreaking project began in 2023.
- M&A Activity
Tilray Acquires HelloMD in Court-Supervised Sale, Adding Direct-to-Patient Digital Infrastructure in Canada
Tilray Brands (TLRY) has acquired HelloMD Corporation’s Canadian medical cannabis assets through a court-supervised insolvency sale, with court approval granted on 29 June 2026.
- Interviews
Green Rush to Grown Up: Cannabis Investment No Longer Needs Hype
Investment in the cannabis industry has long been dominated by specialists, speculators, and momentum traders, but that is beginning to change.
- Medical Cannabis
Who Really Benefits from Britain’s Medical Cannabis System?
Written for Business of Cannabis by Saxon Coop, Founder & CEO of Toke.
- UK & Europe
Ireland’s Cross-Party Drug Committee Calls for Full Decriminalisation. The Government Has Already Said No
Ireland’s Oireachtas Joint Committee on Drugs Use has recommended the full decriminalisation of personal possession of all drugs, calling on the government to repeal Section 3 of the Misuse of Drugs Act 1977.
- Cannabis Daily News
Cannabis News Today — Monday 29 June 2026: DEA Hearing Opens as Cannabis Reaches NYSE
The week’s defining development opened in Arlington, Virginia, on Monday, as a Drug Enforcement Administration court began formal proceedings to determine whether all cannabis should move to Schedule III of the Controlled Substances Act.
- US & Canada
‘A Giant Ship With a Rusty Rudder’: What Six Weeks of Cannabis Rescheduling Has and Hasn’t Changed
On June 29, 2026, one of the most consequential hearings in the history of US cannabis policy, the crucial DEA Administrative Law Judge (ALJ) hearing that could determine whether adult-use cannabis joins state-licensed medical cannabis on Schedule III of the Controlled Substances Act, begins proceedings.
- Prescribers & Clinics
Nine of the Ten Top CBPM Prescribers Are Pharmacists, FOI Data Shows
New data acquired by Business of Cannabis has, for the first time, shed light on the professional types behind England’s CBPM prescribing record, raising further questions about assertions that ‘10 doctors prescribe half of the UK’s medical cannabis’.
- Cultivation
Cannabis Inherits Its Future: What the Eye Can’t See
‘Cannabis Inherits Its Future’ is a three-part feature covering the science, the bottlenecks and the path forward for cannabis breeding, written by Agential Cannabis.
- Cultivation
Cannabis Inherits Its Future: Part 1, The Genetic Legacy Loop
‘Cannabis Inherits Its Future’ is a three-part feature covering the science, the bottlenecks and the path forward for cannabis breeding, written by Agential Cannabis.
- Industry Trends
UK Medical Cannabis Market Growing ‘Faster Than Anyone Expected’
In 2025, the UK imported more than 30,000 kilograms of cannabis-based medicinal products (CBPMs), more than doubling for the second consecutive year, new data from Prohibition Partners shows.
- Cannabis Daily News
Cannabis News Today — Monday 23 June 2026: Virginia Secures Retail Market as Rescheduling Hearing Faces Procedural Challenge
Virginia’s legislature ended years of stalemate on Monday, formally approving a regulated retail cannabis market to open in July 2027.
